Eastwood Bio-Medical Canada Inc (V:EBM) — Stock Price
Eastwood Bio-Medical Canada Inc (V:EBM) is currently trading at CA$1.90 CAD, up 5.56% today. Over the past 52 weeks, shares have ranged between CA$0.44 and CA$1.95. This page tracks Eastwood Bio-Medical Canada Inc's live share price on the V exchange, its daily price and volume history, and — where reported — its income statement, balance sheet, cash flow statement, and earnings history. To see how efficiently this company converts equity into cash flow, see cash flow conversion of Eastwood Bio-Medical Canada Inc.
Eastwood Bio-Medical Canada Inc (EBM) Stock Price Chart — Daily History & Trading Volume
The chart below tracks Eastwood Bio-Medical Canada Inc's daily closing share price and trading volume on the V exchange over the past year, giving a clear view of recent price momentum and liquidity.
Eastwood Bio-Medical Canada Inc Income Statement — Revenue, Profit & Earnings by Year
Eastwood Bio-Medical Canada Inc's annual income statement shows how revenue converts into profit each fiscal year, including gross profit, operating income, EBITDA, and net income.
| Fiscal Year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Total Revenue | CA$782.08K | CA$702.08K | CA$867.94K | CA$1.30 Million | CA$981.05K |
| Cost of Revenue | CA$231.09K | CA$247.69K | CA$427.42K | CA$397.02K | CA$522.68K |
| Gross Profit | CA$550.99K | CA$454.39K | CA$440.51K | CA$902.74K | CA$458.37K |
| Research & Development | — | — | — | — | — |
| SG&A | CA$606.85K | CA$527.08K | CA$666.73K | CA$922.53K | CA$951.85K |
| Total Operating Expenses | CA$1.07 Million | CA$1.14 Million | CA$946.55K | CA$1.03 Million | CA$1.05 Million |
| Operating Income | CA$-292.33K | CA$-437.70K | CA$-506.04K | CA$-128.76K | CA$-590.89K |
| EBITDA | — | — | CA$-398.19K | CA$-21.91K | CA$-485.59K |
| EBIT | — | — | CA$-506.04K | CA$-128.76K | CA$-590.89K |
| Interest Expense | — | CA$6.29K | CA$28.16K | CA$10.71K | CA$2.79K |
| Income Before Tax | CA$-332.77K | CA$-455.87K | CA$-546.60K | CA$-149.88K | CA$-603.59K |
| Income Tax Expense | — | — | CA$-1.00 | CA$10.71K | CA$7.74K |
| Net Income | CA$-332.77K | CA$-455.87K | CA$-546.60K | CA$-160.58K | CA$-611.34K |
Eastwood Bio-Medical Canada Inc Balance Sheet — Assets, Liabilities & Shareholder Equity
The balance sheet below summarizes Eastwood Bio-Medical Canada Inc's financial position at each fiscal year-end — what it owns (assets), what it owes (liabilities), and the resulting shareholder equity.
| Fiscal Year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Total Assets | CA$218.77K | CA$274.29K | CA$489.14K | CA$584.53K | CA$691.12K |
| Total Current Assets | CA$33.12K | CA$43.68K | CA$150.98K | CA$101.46K | CA$57.87K |
| Cash & Equivalents | — | — | — | — | — |
| Short-term Investments | — | — | — | — | — |
| Net Receivables | CA$14.62K | CA$42.88K | CA$82.80K | CA$14.59K | CA$6.02K |
| Inventory | — | — | — | — | — |
| Property, Plant & Equipment | — | — | — | CA$446.01K | CA$549.85K |
| Goodwill | — | — | — | — | — |
| Total Liabilities | CA$1.85 Million | CA$1.57 Million | CA$1.33 Million | CA$878.73K | CA$835.44K |
| Total Current Liabilities | CA$1.85 Million | CA$1.57 Million | CA$1.33 Million | CA$843.98K | CA$804.09K |
| Long-term Debt | — | — | — | CA$34.75K | CA$31.35K |
| Net Debt | CA$60.30K | CA$79.61K | CA$4.63K | CA$22.41K | CA$10.48K |
| Total Stockholder Equity | CA$-1.63 Million | CA$-1.30 Million | CA$-840.80K | CA$-294.20K | CA$-144.32K |
| Retained Earnings | CA$-6.33 Million | CA$-5.99 Million | CA$-5.54 Million | CA$-4.99 Million | CA$-4.84 Million |
Eastwood Bio-Medical Canada Inc Cash Flow Statement — Operating, Investing & Financing Activities
This cash flow statement breaks down how Eastwood Bio-Medical Canada Inc generates and spends cash across operating, investing, and financing activities each fiscal year, including free cash flow and capital expenditures.
| Fiscal Year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Operating Cash Flow | CA$19.30K | CA$-15.22K | CA$-16.89K | CA$-4.29K | CA$-116.21K |
| Capital Expenditures | CA$0.00 | CA$0.00 | CA$0.00 | CA$3.00K | CA$5.57K |
| Free Cash Flow | CA$19.30K | CA$-15.22K | CA$-16.89K | CA$-7.30K | CA$-121.79K |
| Investing Cash Flow | — | — | — | CA$-3.00K | CA$-5.57K |
| Financing Cash Flow | CA$-211.00 | CA$-4.62K | CA$-4.50K | CA$26.27K | CA$20.00K |
| Dividends Paid | — | — | — | — | — |
| Stock-Based Compensation | — | — | — | — | — |
| Depreciation | CA$44.96K | CA$107.54K | CA$107.85K | CA$106.85K | CA$105.30K |
| Change in Cash | CA$19.09K | CA$-19.84K | CA$-21.39K | CA$18.97K | CA$-101.79K |
Eastwood Bio-Medical Canada Inc Earnings History — EPS Actual vs. Analyst Estimates
Track Eastwood Bio-Medical Canada Inc's quarterly earnings per share (EPS) against Wall Street estimates, along with the earnings surprise percentage for each reporting period.
| Report Date | EPS Actual | EPS Estimate | Surprise |
|---|---|---|---|
| Sep 28, 2026 | — | — | — |
| Jun 29, 2026 | — | — | — |
| Mar 02, 2026 | — | — | — |
| Sep 30, 2025 | — | — | — |
| Jul 04, 2025 | — | — | — |
| Jun 30, 2023 | 0.00 | — | — |
| Mar 31, 2023 | 0.00 | — | — |
| Oct 31, 2022 | 0.00 | — | — |